首页> 外文期刊>Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation >Comparison of Subcutaneous Versus Intravenous Alemtuzumab for Graft-Versus-Host Disease Prophylaxis with Fludarabine/Melphalan Based Conditioning in Matched Unrelated Donor Allogeneic Stem Cell Transplant

【24h】

Comparison of Subcutaneous Versus Intravenous Alemtuzumab for Graft-Versus-Host Disease Prophylaxis with Fludarabine/Melphalan Based Conditioning in Matched Unrelated Donor Allogeneic Stem Cell Transplant

机译：匹配的无关供体同种异体干细胞移植中以氟达拉滨/美法仑为基础的皮下注射与静脉注射Alemtuzumab预防移植物抗宿主疾病的比较

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation》 |2016年第1期|共1页
作者
Patel Khilna; Parmar Sapna; Shah Shreya; van Besien Koen; Shore Tsiporah B.; Gergis Usama; Mayers Sebastian;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类治疗学;
关键词

相似文献

外文文献
中文文献
专利

1. Comparison of Subcutaneous versus Intravenous Alemtuzumab for Graft-versus-Host Disease Prophylaxis with Fludarabine/Melphalan-Based Conditioning in Matched Unrelated Donor Allogeneic Stem Cell Transplantation [J] . Patel Khilna, Parmar Sapna, Shah Shreya, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2016,第3期

机译：匹配的无关供体同种异体干细胞移植中氟达拉滨/基于美法仑的条件下皮下和静脉注射Alemtuzumab预防移植物抗宿主疾病的比较
2. Comparison between two fludarabine-based reduced-intensity conditioning regimens before allogeneic hematopoietic stem-cell transplantation: fludarabine|[sol]|melphalan is associated with higher incidence of acute graft-versus-host disease and non-relapse mortality and lower incidence of relapse than fludarabine|[sol]|busulfan [J] . A Shimoni, I Hardan, N Shem-Tov, Leukemia . 2007,第10期

机译：同种异体造血干细胞移植前两种基于氟达拉滨的低强度调理方案的比较：氟达拉滨| [sol] |美法仑与急性移植物抗宿主病发病率高，非复发死亡率和复发率低相关氟达拉滨| [sol] |白消安
3. Comparative study on ATG-thymoglobulin versus ATG-fresenius for the graft-versus-host disease (GVHD) prophylaxis in allogeneic stem cell transplantation from matched unrelated donor: a single-centre experience over the contemporary years [J] . Nicola Polverelli, Michele Malagola, Alessro Turra, Leukemia and lymphoma . 2018,第11a12期

机译：对匹配的无关捐助者的同种异体干细胞移植中的接枝腹膜疾病（GVHD）预防的ATG-Trymoglobulin对atg-Fresenius（GVHD）预防的比较研究
4. Anti-Thymocyte-Globulin (ATG-Fresenius) for Prevention of Acute and Chronic Graft-versus-Host Disease in Pediatric and Adult Recipients of Unrelated Donor Bone Marrow Transplantation [C] . . 2006

机译：抗胸腺细胞球蛋白（ATG-Fresenius）预防无关供体骨髓移植的小儿和成年患者的急性和慢性移植物抗宿主病
5. Genetic Associations in Acute Leukemia Patients After Matched Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation [D] . Rizvi, Abbas A. 2019

机译：匹配的无关供体同种异体造血干细胞移植后急性白血病患者的遗传协会。
6. Comparison of Subcutaneous versus Intravenous Alemtuzumab for Graft-versus-Host Disease Prophylaxis with Fludarabine/Melphalan–Based Conditioning in Matched Unrelated Donor Allogeneic Stem Cell Transplantation [O] . Khilna Patel, Sapna Parmar, Shreya Shah, -1

机译：匹配的无关供体同种异体干细胞移植中氟达拉滨/基于美法仑的条件下皮下和静脉注射Alemtuzumab预防移植物抗宿主疾病的比较
7. Comparison of Subcutaneous Versus Intravenous Alemtuzumab for Graft-Versus-Host Disease Prophylaxis with Fludarabine/Melphalan Based Conditioning in Matched Unrelated Donor Allogeneic Stem Cell Transplant [O] . Khilna Patel, Sapna Parmar, Shreya Shah, 2016

机译：皮下与静脉内Alemtuzumab对匹配无关助给运动同种异体干细胞移植匹配的氟氮素/梅酚基血管疾病预防的静脉内Alemtuzumab

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号